RSS

Aimovig

The European Commission (EC) has approved Novartis’ Aimovig (erenumab) for the prevention of migraine in adults experiencing four or more migraines per month. Read more

News

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. Read more

News

A novel treatment for the prevention of migraines, Aimovig (erenumab-aooe), has received approval from the US Food and Drug Administration (FDA). Read more

News